APA (7th ed.) Citation

P, J., X, L., A, A., B, T., H, T., K, L., . . . J, W. (2025). Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates. Nature communications, 16(1), 1604. https://doi.org/10.1038/s41467-025-56902-x

Chicago Style (17th ed.) Citation

P, Jadhav, et al. "Design of Quinoline SARS-CoV-2 Papain-like Protease Inhibitors as Oral Antiviral Drug Candidates." Nature Communications 16, no. 1 (2025): 1604. https://doi.org/10.1038/s41467-025-56902-x.

MLA (9th ed.) Citation

P, Jadhav, et al. "Design of Quinoline SARS-CoV-2 Papain-like Protease Inhibitors as Oral Antiviral Drug Candidates." Nature Communications, vol. 16, no. 1, 2025, p. 1604, https://doi.org/10.1038/s41467-025-56902-x.